Provided by Tiger Fintech (Singapore) Pte. Ltd.

Syndax Pharmaceuticals

13.00
+0.08000.62%
Post-market: 13.000.00000.00%16:20 EDT
Volume:1.34M
Turnover:17.50M
Market Cap:1.12B
PE:-3.49
High:13.59
Open:13.35
Low:12.81
Close:12.92
Loading ...

Syndax Pharmaceuticals Q4 Loss Widens

MT Newswires Live
·
03 Mar

Syndax: Q4 Earnings Snapshot

Associated Press Finance
·
03 Mar

Earnings Flash (SNDX) Syndax Pharmaceuticals Posts Q4 Net Loss $-1.10 a Share, vs. FactSet Est of $-0.84 Loss

MT Newswires Live
·
03 Mar

Syndax Pharmaceuticals Q4 2024 GAAP EPS $(1.10) Misses $(1.01) Estimate, Sales $7.68M Miss $85.91M Estimate

Benzinga
·
03 Mar

BRIEF-Syndax Pharmaceuticals Q4 EPS USD -1.1

Reuters
·
03 Mar

Syndax Pharmaceuticals Inc - Has $692.4 Million in Cash, Expected to Fund Profitability

THOMSON REUTERS
·
03 Mar

Syndax Pharmaceuticals Q4 Net Income USD -94.17 Million

THOMSON REUTERS
·
03 Mar

Syndax Pharmaceuticals Q4 Operating Income USD -96.365 Million

THOMSON REUTERS
·
03 Mar

Syndax Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

GlobeNewswire
·
03 Mar

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
03 Mar

Syndax Pharmaceuticals Inc expected to post a loss of 23 cents a share - Earnings Preview

Reuters
·
28 Feb

Syndax Announces Participation in March Investor Conferences

GlobeNewswire
·
25 Feb

Syndax to Announce Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call and Webcast on March 3, 2025

GlobeNewswire
·
24 Feb

Syndax Pharmaceuticals Inc : Guggenheim Cuts Target Price to $32 From $35

THOMSON REUTERS
·
13 Feb

Top Executives Make Significant Moves with Syndax Pharmaceuticals Stock!

TIPRANKS
·
13 Feb

Syndax Pharmaceuticals Up Over 9%, on Pace for Largest Percent Increase Since December 2022 -- Data Talk

Dow Jones
·
07 Feb

Barclays Sticks to Their Buy Rating for Syndax Pharmaceuticals (SNDX)

TIPRANKS
·
06 Feb

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

PR Newswire
·
05 Feb

Stifel Nicolaus Keeps Their Buy Rating on Syndax Pharmaceuticals (SNDX)

TIPRANKS
·
31 Jan

Syndax Announces Participation in February Investor Conferences

PR Newswire
·
30 Jan